Germany
· Delayed Price · Currency is EUR Kangji Medical Holdings Statistics
Total Valuation
FRA:50J has a market cap or net worth of EUR 1.04 billion. The enterprise value is 885.74 million.
| Market Cap | 1.04B |
| Enterprise Value | 885.74M |
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | May 27, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 352.61M |
Valuation Ratios
The trailing PE ratio is 13.46.
| PE Ratio | 13.46 |
| Forward PE | n/a |
| PS Ratio | 7.76 |
| PB Ratio | 2.98 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | 15.51 |
| P/OCF Ratio | 13.97 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.40, with an EV/FCF ratio of 13.26.
| EV / Earnings | 11.51 |
| EV / Sales | 7.25 |
| EV / EBITDA | 13.40 |
| EV / EBIT | 14.11 |
| EV / FCF | 13.26 |
Financial Position
The company has a current ratio of 7.92, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.92 |
| Quick Ratio | 6.19 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 849.55 |
Financial Efficiency
Return on equity (ROE) is 17.38% and return on invested capital (ROIC) is 10.20%.
| Return on Equity (ROE) | 17.38% |
| Return on Assets (ROA) | 9.40% |
| Return on Invested Capital (ROIC) | 10.20% |
| Return on Capital Employed (ROCE) | 20.33% |
| Revenue Per Employee | 132,543 |
| Profits Per Employee | 76,408 |
| Employee Count | 1,007 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.98% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.98% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 0.72 |
| Relative Strength Index (RSI) | 50.69 |
| Average Volume (20 Days) | 18 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:50J had revenue of EUR 133.47 million and earned 76.94 million in profits. Earnings per share was 0.07.
| Revenue | 133.47M |
| Gross Profit | 105.55M |
| Operating Income | 71.50M |
| Pretax Income | 90.62M |
| Net Income | 76.94M |
| EBITDA | 74.45M |
| EBIT | 71.50M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 164.42 million in cash and 465,145 in debt, giving a net cash position of 163.96 million.
| Cash & Cash Equivalents | 164.42M |
| Total Debt | 465,145 |
| Net Cash | 163.96M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 347.89M |
| Book Value Per Share | 0.29 |
| Working Capital | 238.60M |
Cash Flow
In the last 12 months, operating cash flow was 74.12 million and capital expenditures -7.32 million, giving a free cash flow of 66.80 million.
| Operating Cash Flow | 74.12M |
| Capital Expenditures | -7.32M |
| Free Cash Flow | 66.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 79.08%, with operating and profit margins of 53.57% and 57.65%.
| Gross Margin | 79.08% |
| Operating Margin | 53.57% |
| Pretax Margin | 67.90% |
| Profit Margin | 57.65% |
| EBITDA Margin | 55.78% |
| EBIT Margin | 53.57% |
| FCF Margin | 50.05% |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 22.22%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 22.22% |
| Dividend Growth (YoY) | 641.30% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 283.32% |
| Buyback Yield | -0.29% |
| Shareholder Yield | 21.94% |
| Earnings Yield | 7.43% |
| FCF Yield | 6.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:50J has an Altman Z-Score of 16.57.
| Altman Z-Score | 16.57 |
| Piotroski F-Score | n/a |